Dr Andrew Willis

Dr Andrew Willis is a researcher with over 10 years’ experience in the development, delivery and evaluation of screening and prevention programmes focussing on cardiometabolic conditions such as type 2 diabetes and hypertension, in the UK, and as part of international research collaborations. His research interests include the development of novel effective public engagement strategies, encouraging diversity and inclusion in clinical trials and science communication.